Pruritus

Dermatologic Clinics

Volumn 30, Issue 2, 2012, Pages 309-321

  Chen, Suephy C ^a,b  

^a ATLANTA VA MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Itch; Pruritus; Quality of life

Indexed keywords

AGGRESSION; CLINICAL ASSESSMENT TOOL; DEPRESSION; DERMATOLOGY LIFE QUALITY INDEX; DISEASE SEVERITY; EPPENDORF ITCH QUESTIONNAIRE; HUMAN; ITCHYQOL; PATIENT BENEFIT INDEX FOR PRURITUS; PREVALENCE; PRIORITY JOURNAL; PRURITUS; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; SHORT FORM 36; SHORT FORM ITCH QUESTIONNAIRE; SKINDEX; SOCIAL PSYCHOLOGY; SYMPTOM CHECKLIST 90; SYMPTOMATOLOGY; SYSTEMATIC REVIEW; VETERAN; VISUAL ANALOG SCALE; WELLBEING;

HEALTH STATUS; HUMANS; PRURITUS; QUALITY OF LIFE; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 84863064439     PISSN: 07338635     EISSN: 15580520     Source Type: Journal    
DOI: 10.1016/j.det.2011.11.012     Document Type: Review

References (47)

1. Samuel Hafenreffer. Available at: Accessed November 24, 2011. http://en.wikipedia.org/wiki/Samuel_Hafenreffer.
2. Wolkenstein P., Grob J., Bastuji-Garin S., et al. French people and skin diseases: results of a survey using a representative sample. Arch Dermatol 2003, 139(12):1614-1619.
3. Matterne U., Apfelbacher C., Loerbroks A., et al. Prevalence, correlates and characteristics of chronic pruritus: a population-based cross-sectional study. Acta Derm Venereol 2011, 91(6):674-679.
4. Fleischer A.J., Herbert C., Feldman S., et al. Diagnosis of skin disease by nondermatologists. Am J Manag Care 2000, 6(10):1149-1156.
5. Globe D., Bayliss M., Harrison D. The impact of itch symptoms in psoriasis: results from physician interviews and patient focus groups. Health Qual Life Outcomes 2009, 7:62.
6. Weisshaar E., Apfelbacher C., Jäger G., et al. Pruritus as a leading symptom: clinical characteristics and quality of life in German and Ugandan patients. Br J Dermatol 2006, 155(5):957-964.
7. Reddy V., Shimada S., Sikand P., et al. Cathepsin S elicits itch and signals via protease-activated receptors. JInvest Dermatol 2010, 130(5):1468-1470.
8. Reddy V., Iuga A., Shimada S., et al. Cowhage-evoked itch is mediated by a novel cysteine protease: a ligand of protease-activated receptors. JNeurosci 2008, 28(17):4331-4335.
9. Maddison B., Parsons A., Sangueza O., et al. Retrospective study of intraepidermal nerve fiber distribution in biopsies of patients with nummular eczema. Am J Dermatopathol 2011, 33(6):621-623.
10. Papoiu A., Tey H., Coghill R., et al. Cowhage-induced itch as an experimental model for pruritus. A comparative study with histamine-induced itch. PLoS One 2011, 6(3):e17786.
11. Paul J., Pieper B., Templin T. Itch: association with chronic venous disease, pain, and quality of life. JWound Ostomy Continence Nurs 2011, 38(1):46-54.
12. El-Baalbaki G., Razykov I., Hudson M., et al. Association of pruritus with quality of life and disability in systemic sclerosis. Arthritis Care Res 2010, 62(10):1489-1495.
13. van Os-Medendorp H., Eland-de Kok P., Grypdonck M., et al. Prevalence and predictors of psychosocial morbidity in patients with chronic pruritic skin diseases. JEur Acad Dermatol Venereol 2006, 20(7):810-817.
14. Finlay A., Kahn G. Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use. Clin Exp Dermatol 1994, 19:210-216.
15. Hongbo Y., Thomas C., Harrison M., et al. Translating the science of quality of life into practice: what do dermatology life quality index scores mean?. JInvest Dermatol 2005, 125(4):659-664.
16. Chularojanamontri L., Sethabutra P., Kulthanan K., et al. Dermatology life quality index in Thai patients with systemic sclerosis: a cross-sectional study. Indian J Dermatol Venereol Leprol 2011, 77(6):683-687.
17. Szepietowski J., Balaskas E., Taube K., et al. Quality of life in patients with uraemic xerosis and pruritus. Acta Derm Venereol 2011, 91(3):313-317.
18. Panahi Y., Davoudi S., Sadr S., et al. Impact of pruritus on quality of life in sulfur mustard-exposed Iranian veterans. Int J Dermatol 2008, 47(6):557-561.
19. Zachariae R., Zachariae C., Lei U., et al. Affective andsensory dimensions of pruritus severity: associations with psychological symptoms and quality of life in psoriasis patients. Acta Derm Venereol 2008, 88(2):121-127.
20. Reich A., Hrehorow E., Szepietowski J. Pruritus is an important factor negatively influencing the well-being of psoriatic patients. Acta Derm Venereol 2010, 90:257-263.
21. Weber M., Fontes Neto Pde T., Prati C., et al. Improvement of pruritus and quality of life of children with atopic dermatitis and their families after joining support groups. JEur Acad Dermatol Venereol 2008, 22(8):992-997.
22. Chren M., Lasek R., Flocke S., et al. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol 1997, 133:1433-1440.
23. Chren M., Lasek R., Sahay A., et al. Measurement of properties of Skindex-16, a brief quality-of-life measure for patients with skin diseases. JCutan Med Surg 2001, 5(2):105-110.
24. Murota H., Kitaba S., Tani M., et al. Impact of sedative and non-sedative antihistamines on the impaired productivity and quality of life in patients with pruritic skin diseases. Allergol Int 2010, 59(4):345-354.
25. Tessari G., Dalle Vedove C., Loschiavo C., et al. The impact of pruritus on the quality of life of patients undergoing dialysis: a single centre cohort study. JNephrol 2009, 22(2):241-248.
26. Duque M., Yosipovitch G., Chan Y., et al. Itch, pain, and burning sensation are common symptoms in mild to moderate chronic venous insufficiency with an impact on quality of life. JAm Acad Dermatol 2005, 53(3):504-508.
27. Darsow U., Mautner V., Scharein E., et al. Der Eppendorfer Juckreizfragebogen. Hautarzt 1997, 48:730-733.
28. Yosipovitch G. Itch questionnaires as tools for itchevaluation. Itch 2004, 169-182. Marcel Dekker, Inc, New York. G. Yosipovitch, M. Greaves, A. Fleischer (Eds.).
29. Yosipovitch G., Zucker I., Boner G., et al. A questionnaire for the assessment of pruritus: validation in uremic patients. Acta Derm Venereol 2001, 81:108-111.
30. Melzack R. The short-form McGill Pain Questionnaire. Pain 1987, 30:191-197.
31. Parent-Vachon M., Parnell L., Rachelska G., et al. Cross-cultural adaptation and validation of the Questionnaire for Pruritus Assessment for use in the French Canadian burn survivor population. Burns 2008, 34(1):71-92.
32. Yosipovitch G., Goon A., Wee J., et al. The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis. Br J Dermatol 2000, 143:969-973.
33. Yosipovitch G., Ansari N., Goon A., et al. Clinical characteristics of pruritus in chronic idiopathic urticaria. Br J Dermatol 2002, 147:32-36.
34. Yosipovitch G., Goon A., Wee J., et al. Itch characteristics in Chinese patients with atopic dermatitis using a new questionnaire for the assessment of pruritus. Int J Dermatol 2002, 41:212-216.
35. Zucker I., Yosipovitch G., David M., et al. Prevalence and characterization of uremic pruritus in patients undergoing hemodialysis: uremic pruritus is still a major problem for patients with end-stage renal disease. JAm Acad Dermatol 2003, 49:842-846.
36. Amatya B., Wennersten G., Nordlind K. Patients' perspective of pruritus in chronic plaque psoriasis: a questionnaire-based study. JEur Acad Dermatol Venereol 2008, 22(7):822-826.
37. Majeski C., Johnson J., Davison S., et al. Itch Severity Scale: a self-report instrument for the measurement of pruritus severity. Br J Dermatol 2007, 156(4):667-673.
38. Daudén E., Sánchez-Perez J., Prieto M., et al. Validation of the Spanish Version of the Itch Severity Scale: the PSEDA study. Actas Dermosifiliogr 2011, 102(7):527-536.
39. Zachariae R., Lei U., Hædersdal M., et al. Itch severity and quality of life in patients with pruritus: preliminary validity of a Danish adaptation of the Itch Severity Scale. Acta Derm Venereol 2011, [Epub ahead of print].
40. Acar B., Karabulut H., Sahin Y., et al. New treatment strategy and assessment questionnaire for external auditory canal pruritus: topical pimecrolimus therapy and Modified Itch Severity Scale. JLaryngol Otol 2009, 124:147-151.
41. Elman S., Hynan L., Gabriel V., et al. The 5-D itch scale: a new measure of pruritus. Br J Dermatol 2010, 162(3):587-593.
42. Desai N., Poindexter G., Monthrope Y., et al. Apilot quality-of-life instrument for pruritus. JAm Acad Dermatol 2008, 59(2):234-244.
43. Chen S, Nguyen L, Pugliese S, etal. Pruritus in CTCL patients: prevalence and quality of life impact. First World Congress of Cutaneous Lymphomas. Chicago, September 25, 2010. p. 101.
44. Blome C., Augustin M., Siepmann D., et al. Measuring patient-relevant benefits in pruritus treatment: development and validation of a specific outcomes tool. Br J Dermatol 2009, 161(5):1143-1148.
45. Weisshaar E., Ständer S., Gieler U., et al. Development of a German language questionnaire for assessing chronic pruritus (AGP-questionnaire): background and first results. Hautarzt 2011, 62(12):914-927.
46. Weisshaar E., Diepgen T., Bruckner T., et al. Itch intensity evaluated in the German Atopic Dermatitis Intervention Study (GADIS): correlations with quality of life, coping behaviour and SCORAD severity in 823 children. Acta Derm Venereol 2008, 88(3):234-239.
47. Kini S., DeLong L., Veledar E., et al. The impact of pruritus on quality of life: the skin equivalent of pain. Arch Dermatol 2011, 147(10):1153-1156.